Skip to main content

Table 3 Outcomes of the β-blockers and non-β-blocker therapy groups

From: Association between β-blocker use and mortality in critically ill patients: a nested cohort study

  Categorical Variables
Variable β-blocker
N = 89
Non β-blocker
N = 434
P value Risk
aOR 95% CI P value
ICU Mortality, (n%) 18 (20.2) 62 (14.3) 0.16 1.56 0.83–2.9 0.16
Hospital Mortality, (n%) 34 (38.2) 121 (27.9) 0.05 1.09 0.65, 1.83 0.73
180-day mortality, (n%) 19 (23.0) 69 (17.5) 0.25 0.73 0.38–1.38 0.33
Sepsis, (n%) 30 (33.7) 173 (39.9) 0.27 1.20 0.71–2.02 0.49
Severe Sepsis, (n%) 23 (25.8) 102 (23.5) 0.63 1.68 0.95–2.97 0.08
  Continuous Variables
     Parameter estimate 95% CI P value
Mechanical ventilation duration (days), mean ± SD 10.5 ± 13.3 8.7 ± 8.7 0.11 2.66 0.34–4.99 0.17
ICU LOS (days), mean ± SD 11.3 ± 14.0 10.0 ± 8.9 0.23 1.99 −0.43-4.41 0.22
Hospital LOS (days), mean ± SD 59.5 ± 101.9 55.0 ± 75.7 0.63 7.95 −11.68-27.58 0.34
  1. aOR adjusted odds ratio, CI confidence interval, ICU intensive care unit, LOS length of stay